Overzicht Proefschriften

Tips in using the search/filter fields

Tips in using the search/filter fields
Select on a part of the content: ede Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes) Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010 Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011 Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.
Go to page:
  • of 6

Displaying 1-50 of 270 results.
TitelPromovendusPromotor 1Promotor 2Copromotor 1Copromotor 2UniversiteitPromotiejaarTrefwoorden
Targeting proteostasis in atrial fibrillationZhang D., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2015Atrial fibrillation; Modelling-&-simulations;
Novel directions in therapy against age-related vascular diseaseWu H., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2014Pharmacology; Cardiovascular disease;
Medication Optimization; exploring the use of a clinical decision support systemWit H.A.J.M. de, PhDSchols J.M.G.A., prof. dr.Kuy P.H.M. van der, dr.Janknegt R., PharmD PhDUniversiteit Maastricht (UM)2016Clinical pharmacology; Clinical rules; CDSS
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillationWiersma M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2016Atrial fibrillation;
Novel protective approaches in ischemia-reperfusion injury. In vivo studies in animals and humansWever K.E., PhDRongen G.A., prof. dr.Masereeuw R., prof. dr.Warlé M.C., dr.Radboud Universiteit (RU)2012Renal, ischemia/reperfusion injury, remote ischemic preconditioning, Annexin A5, animal and human research
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and diseaseWeigand K.M., PhDRussel F.G.M., prof. dr.Radboud Universiteit (RU)2015
Determinants of treatment outcomes in epilepsyWassenaar M., PhDEgberts A.C.G., prof. dr.Leijten F.S.S., dr.Uijl S.G., dr.Universiteit Utrecht (UU)2014Epilepsy; Treatment; Treatment outcomes; Quality of life; Patient-perspectives; Clinical determinants; Seizures; Pharmacology; Daily practice; Community-based;
Reversible suppression of hemostasis in hibernation and hypothermiaVrij E.L. deHenning R.H., prof. dr.Bouma H.R., PhDRijksuniversiteit Groningen (RUG)2019Hypothermia; Hibernation;
Treatment response in childhood asthmaVijverberg S.J.H., PhDRaaijmakers J.A.M., prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2014Treatment outcomes; Children; Asthma;
Preeclampsia, the renin-angiotensin-aldosterone system and beyondVerdonk K., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2015Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system;
Myogenic constriction in renal failure; cause and therapyVavrinec P., PhDHenning R.H., prof. dr.Dokkum R.P.E. van, dr.Buikema J.H., dr.Rijksuniversiteit Groningen (RUG)2012renal failure myogenic constriction
The therapeutic potential of Indoleamine 2.3-dioxygenase in kidney transplantationVavrinacova-Yaghi D., PhDHenning R.H., prof. dr.Sandovici M., dr.Seelen M.A.J., dr.Rijksuniversiteit Groningen (RUG)2014Pharmacology; kidney transplantation Indoleamine 2.3-dioxygenase
Making better prescribers during a context-based pharmacotherapy learning programmeTichelaar J., dr.Vries Th.P.G.M. de, prof. dr. MDRichir M.C., MD PhDVrije Universiteit Amsterdam (VU)2016pharmacotherapy; pharmacotherapy education; context based learning; clinical pharmacology; prescribing
New therapeutic targets in cardiovascular disease: focus on the renin-angiotensin system and lipid metabolismSun YDanser A.H.J., prof. dr.Lu X., PhDErasmus Universiteit Rotterdam (EUR)2020Renin-angiotensin system; lipid metabolism; Vascular reactivity; Pharmacology; Treatment options;
Optimisation of first clinical studies in special populations: towards semi-physiological pharmacokinetics Strougo A., PhDDanhof M., prof. dr.Freijer J., dr.Yassen A., dr.Universiteit Leiden (UL)2015Special-population; Model-based; PK-model; Paediatrics; Children; Hepatic and renal impairment; Semi-physiological; Population approach; PBPK;
Assessing the impact of gout:validating and understanding outcomesSpaetgens B.P.A., drBoonen A.E.R.C.H., prof. dr.Vries F. de, prof. dr.Universiteit Maastricht (UM)2017
Physical causes of dosing errors in patients receiving multi-infusion therapySnijder R.A., PhDEgberts A.C.G., prof. dr.Timmerman A.M.D.E., dr. ir.Konings M.K., dr.Universiteit Utrecht (UU)2016Infusion; Multi-infusion; Patient safety; Fluid mechanics; Physics; Modeling errors; Adverse events;
Shaping the pharmacokinetic landscape for renally cleared antibiotics in obesity: Studies in adults, adolescents and childrenSmit C., PhDKnibbe C.A.J., prof. dr.Dongen H.P.A. van, dr.Brüggemann R.J.M., PhDUniversiteit Leiden (UL)2020Obesity; Morbid obesity; Pharmacokinetics; Obese children; Obese adolescents; Gentamicin; Tobramycin; Aminoglycosides; Vancomycin; Renal clearance; Population pharmacokinetics; Antibiotics; Individualized dosing; Adolescents;
Biomarkers as assessment of drug efficacy in cardiovascular diseaseSmink P.A., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Bakker S.J.L., prof. dr.Rijksuniversiteit Groningen (RUG)2013cardiovascular disease biomarkers drug efficacy
Characterization and re-evaluation of experimental pain models in healthy subjectsSiebenga P.SCohen A.F., prof. dr.Universiteit Leiden (UL)2020Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala
The alternative renin-angiotensin system: exploration of its therapeutic potentialSevá Pessôa B., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2015Pharmacology; Cardiovascular disease; Renin-angiotensin system;
Clinical pharmacological studies in tuberculosis patientsSemvua H.H., PhDBurger D.M., prof. dr.Aarnoutse R.E., dr.Boeree M.J., dr.Radboud Universiteit (RU)2014Clinical pharmacology; Pharmacokinetics; Tuberculosis
Learning in a student-run clinic: a new concept to improve medical education in pharmacotherapySchutte T., PhDAgtmael M.A. van, prof. dr.Richir M.C., MD PhDTichelaar J., dr.Vrije Universiteit Amsterdam (VU)2018Pharmacotherapy education; Student-run clinic; Medical education; Workplace learning; Undergraduate education;
Pharmacy Preparations: European quality standards and regulationScheepers H., drNeef C., prof. dr.Universiteit Maastricht (UM)2017Pharmacy policy;
Natriuretic peptides, diagnostics and prognostic biomarkersRutte J.H.W., dr.Danser A.H.J., prof. dr.Meiracker A.H. van den, dr.Erasmus Universiteit Rotterdam (EUR)2010Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system;
Vascular Effects of Current and Novel Antimigraine DrugsRubio Beltrán AEDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2019Migraine; Vascular reactivity; Drug efficacy; Pharmacology;
Bioanalysis and biotransformation of tyrosine kinase inhibitors in oncologyRood J.J.M., PhDBeijnen J.H., prof. dr.Sparidans R.W., dr.Universiteit Utrecht (UU)2019
Early phase clinical drug development for HPV-induced disorders: novel tools and treatmentsRijsbergen M.Burggraaf J., prof. dr.Rissmann R, prof.dr.Poelgeest M.I.E. van, dr.Universiteit Leiden (UL)2020HPV-induced diseases;
Optmizing long-term care for hiv-infected patients in ThailandRamautarsing R.A., PhDBurger D.M., prof. dr.Wit F.W.N.M., dr.Wijgert J.H.H.M. van de, dr.Universiteit van Amsterdam (UvA)2013HIV; clinical pharmacology
Preclinical molecular imaging of target expression and target dynamics in cancer. Pool M., PhDVries E.G.E. de, prof. dr.Lub-de Hooge M.N., dr.Terwisscha van Scheltinga A.G.T., PhDRijksuniversiteit Groningen (RUG)2017
Adherence to antiretroviral combination therapy in children : what a difference half a day makes...Piana C., PhDDanhof M., prof. dr.Della Pasqua O.E., dr.Universiteit Leiden (UL)2013Paediatrics; Antiretroviral combination therapy; Compliance; Antiretroviral drugs; Paediatric populations; Drug combinations; Model-based; Covariate analysis; Predictive pharmacokinetic models; Clinical trial simulations; Adherence; Forgiveness of non-adherence;
Methodological approaches to the pharmacogenomics of statinsPeters B.J.M., dr.Boer A. de, prof. dr.Maitland-van der Zee A.H., prof. dr.Klungel O.H., prof. dr.Universiteit Utrecht (UU)2010Methodology; Statins; Pharmacogenomics;
COMPARE: Care in Oncolytic Medication surveillance:Pharmacovigilance, Acceptability, Risks and EventsOijen B.P.C. van, dr.Schouten H.C., prof. dr.Kuy P.H.M. van der, dr.Janknegt R., PharmD PhDUniversiteit Maastricht (UM)2015Chemotherapy; Clinical pharmacology; Pharmaceutical care;
Monitoring patients using psychotropic drugsNederlof M., PhDEgberts A.C.G., prof. dr.Heerdink E.R., dr.Universiteit Utrecht (UU)2018Therapeutic drug monitoring; Biomarkers; Benefit-risk assessment; Psychotropic drugs; Psychiatry; Antidepressants; Antipsychotics
Driving-impairing medicines and traffic safety: patients' perspectivesMonteiro S.P., PhDGier J.J. de, prof. dr.Dijk C.E.M.J. van, dr. ir.Rijksuniversiteit Groningen (RUG)2014
Aortic pathology and the role of the renin-angiotensin systemMolzer E., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Cardiovascular disease; Renin-angiotensin system;
Lithium in older patients : treatment patterns and somatic adverse effectsMelick E.J.M. van, PhDEgberts A.C.G., prof. dr.Wilting I., dr.Universiteit Utrecht (UU)2014Lithium; Older patients; Pharmacodynamics; Pharmacokinetics; Antidepressants;
Loss of proteostasis as a substrate for Atrial Fibrilation.Meijering R.A.M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2014Atrial fibrillation; Proteostasis;
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraineMehrotra S., dr.Saxena P.R., prof. dr.Danser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2006Cardiovascular disease; Pharmacology;
The role of differentiation factor 15 in diabetic kidney injuryMazagová M., PhDHenning R.H., prof. dr.Deelman L.E., dr.Rijksuniversiteit Groningen (RUG)2012Diabetic kidney disease; Growth differentiation factor 15;
HIV treatment: a clinical pharmacology perspectiveLuin M. van, dr.Hekster Y.A., prof. dr.Burger D.M., prof. dr.Richter C., dr.Radboud Universiteit (RU)2010Clinical pharmacology; Pharmacokinetics; HIV; Therapeutic drug monitoring; drug-drug interactions; antiretroviral drugs
Optimizing protease inhibitor-based antiretroviral therapy for HIV-1 infected Thai adults and childrenLugt J. van der, dr.Lange J.M.A., prof. dr.Ananworanich J., dr.Burger D.M., prof. dr.Universiteit van Amsterdam (UvA)2010Antiretroviral; HIV; Pharmacokinetics; Clinical pharmacology; therapeutic drug monitoring
The (pro)renin receptor: moving away from prorenin?Lu X., PhDDanser A.H.J., prof. dr.Meima M.E., dr.Erasmus Universiteit Rotterdam (EUR)2014Cardiovascular disease; Pharmacology; Prorenin;
Comorbidities, complications and treatment of childhood obesityLentferink Y.E., PhDKnibbe C.A.J., prof. dr.Vorst M.M.J. van der, dr.Universiteit Leiden (UL)2019Children; Obesity; Asthma; ADHD; Insulin resistance; Metformin; Cardiovascular diseases; Obese children; Arterial stiffness; Skin autofluorescence;
Hypertension and renal toxicity during angiogenesis inhibition: Salt dependency and treatment optionsLankhorst S.Danser A.H.J., prof. dr.Meiracker A.H. van den, dr.Kappers M.H.W., PhDErasmus Universiteit Rotterdam (EUR)2016Hypertension; Renal function; Treatment options
Pharmaceutical development, preclinical research and clinical application of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDPLange R., PhDHendrikse N.H., prof. dr.Heine R. ter, dr.Bloemendal H.J., dr.Vrije Universiteit Amsterdam (VU)2017Radiopharmaceutics; Pharmaceutical development; Rhenium;
Neurovascular pharmacology of migraine: epigenetics and sex hormonesLabruijere S., PhDDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2014Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology;
Peripheral Projections of the Trigeminovascular System as Antimigraine TargetLabastida Ramírez ADanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2019Migraine; Vascular reactivity; Pharmacology;
Intranasal drug delivery in migraineKuy P.H.M. van der, dr.Merkus F.W.H.M., prof. dr.Lohman J.J.H.M., dr.Universiteit Leiden (UL)2003Migraine; Intranasal
(Pro)renin revisited: new insights from studies in mast cellsKrop M., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2009Cardiovascular disease; Pharmacology; Prorenin;
Go to page:
  • of 6